Table 1.
Patients’ characteristics
| n (%) | Mean ± SD | |
|---|---|---|
| Number of patients | 153 (100) | |
| Gender (female) | 92 (62.4) | |
| Disease duration (years) at first RTX infusion | 8.17 ± 8.02 | |
| Mean age (years) at disease onset | 33.58 ± 11.97 | |
| Mean age (years) at first RTX infusion | 41.69 ± 12.35 | |
| Follow-up (months) | 26.28 ± 21.08 | |
| RRMS | 72 (45.9) | |
| Gender (female) | 50 (69.5) | |
| Disease duration (years) at first RTX infusion | 6.38 ± 5.89 | |
| Mean age (years) at first RTX infusion | 36.56 ± 9.49 | |
| Follow-up (months) | 24.28 ± 19.52 | |
| SPMS | 60 (38.2) | |
| Gender (female) | 28 (46.6) | |
| Disease duration (years) at first RTX infusion | 12.93 ± 9.71 | |
| Mean age (years) at first RTX infusion | 45.93 ± 10.81 | |
| Follow-up (months) | 28.02 ± 23.97 | |
| Patients with relapses in SPMS | 26 (43.3) | |
| NMO/NMOSD | 21 (13.3) | |
| Gender (female) | 14 (66.7) | |
| Disease duration (years) at first RTX infusion | 3.09 ± 4.72 | |
| Mean age (years) at first RTX infusion | 44.24 ± 17.11 | |
| Follow-up (months) | 30.81 ± 19.13 |